206 related articles for article (PubMed ID: 22207230)
1. Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry.
Tamburino C; Capodanno D; Di Salvo ME; Sanfilippo A; Cascone I; Incardona V; Longo G; Giacoppo D; Capranzano P; Sgroi C; Ussia G; Monaco A; La Manna A
EuroIntervention; 2012 Jan; 7(9):1062-8. PubMed ID: 22207230
[TBL] [Abstract][Full Text] [Related]
2. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
Tamburino C; La Manna A; Di Salvo ME; Sacchetta G; Capodanno D; Mehran R; Dangas G; Corcos T; Prati F
JACC Cardiovasc Interv; 2009 Mar; 2(3):197-204. PubMed ID: 19463426
[TBL] [Abstract][Full Text] [Related]
3. Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry.
Bocksch W; Pomar F; Dziarmaga M; Tresukosol D; Ismail O; Janek B; Carlsson J; Simon JP;
Catheter Cardiovasc Interv; 2010 Jan; 75(1):78-85. PubMed ID: 19739262
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
5. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
7. Six-month clinical outcomes of Firebird 2TM sirolimus-eluting stent implantation in real-world patients with coronary artery diseases.
Ge JB; Zhang F; Qian JY; Ge L; Liu XB; Zhou J
Chin Med J (Engl); 2011 Mar; 124(6):831-5. PubMed ID: 21518588
[TBL] [Abstract][Full Text] [Related]
8. Early and mid-term clinical outcomes with the CATANIA coronary stent system vs. bare metal stents in patients with coronary artery disease.
Capodanno D; La Manna A; Di Salvo ME; Sanfilippo A; Corcos T; Tamburino C
Cardiovasc Revasc Med; 2009; 10(4):216-20. PubMed ID: 19815167
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
10. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
[TBL] [Abstract][Full Text] [Related]
11. Resolute Italian study in all comers: immediate and one-year outcomes.
Romagnoli E; Godino C; Ielasi A; Gasparini G; Tzifos V; Sciahbasi A; Lioy E; Presbitero P; Colombo A; Sangiorgi G
Catheter Cardiovasc Interv; 2012 Mar; 79(4):567-74. PubMed ID: 21805557
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
[TBL] [Abstract][Full Text] [Related]
13. One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry.
Neumann FJ; Widimsky P; Belardi JA
EuroIntervention; 2012 Feb; 7(10):1181-8. PubMed ID: 22334317
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
[TBL] [Abstract][Full Text] [Related]
15. One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I).
Ahmed WH; Zambahari R; Al-Rashdan I; Al Naeemi A; Saeed FA; Mascioli S
J Interv Cardiol; 2008 Dec; 21(6):512-8. PubMed ID: 18973513
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
[TBL] [Abstract][Full Text] [Related]
17. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
[TBL] [Abstract][Full Text] [Related]
18. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry.
Buszman P; Trznadel S; Milewski K; Rzeźniczak J; Przewłocki T; Kośmider M; Wójcik J; Janczak J; Zurakowski A; Kondys M; Król M; Kinasz L; Jaklik A; Rzeszutko Ł; Kałuza GL; Kiesz S; Gil R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):51-7. PubMed ID: 18098182
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
